You are here

Key to Symbols

Standard Practice Standard Process: Specific for trials within Directive's scope
Legal Requirement Legal Requirement: Specific for trials within Directive's scope
gdPractice Good Practice: Specific for trials within Directive's scope
Standard practice with wider relevance Standard Process: Relevant to all trials
Legal requirement with wider relevance Legal Requirement: Relevant to all trials
Good practice with wider relevance Good Practice: Relevant to all trials
Important Important
New New

Is the trial within the scope of the UK Regulations ?

There are a number of steps to follow before a trial can commence. The first step is to confirm that the trial falls within the scope of the UK Regulations. If it does, then the trial protocol should be written and funding sought, if required, with the regulations in mind. A Sponsor must be identified and a EudraCT number obtained, followed by authorisation from MHRA (Clinical Trial Authorisation) and approval by an Ethics Committee. R&D approval is also required before a trial can commence in any clinical site.  These steps can be done in parallel.

Trials that are outside the scope of the UK Regulations must still comply with the NHS Research Governance Framework. A Sponsor must be identified and approval obtained from an Ethics Committee and relevant NHS R&D departments.

MHRA have released an algorithm to help you determine if your trial falls with in the scope of the Directive. See the first resource below.

 

 

Resources

MHRA webpages

Visit the Clinical Trials section of the MHRA website

FAQs

Your frequently asked questions answered.